Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study: Pod e-cigarettes are less damaging to health than traditional cigarettes

Cigarette smoking causes more than 480,000 deaths each year in the United States, according to federal government data -- and some smokers find it nearly impossible to quit. Many of these smokers use regular, or combustible, cigarettes.

18 Nov 2020

New data highlights the gaps in care for children with familial hypercholesterolemia

Children born with a common genetic condition, familial hypercholesterolemia (FH), are at increased risk for atherosclerotic cardiovascular disease (ASCVD) early in life.

18 Nov 2020

Association between periodontal disease and atherosclerosis in patients with rheumatoid arthritis

Rates of both periodontal disease and cardiovascular disease are elevated in individuals with rheumatoid arthritis.

18 Nov 2020

Algorithm-driven program improves cholesterol, blood pressure levels

Using a remotely-delivered, algorithm-driven program for disease management, patients experienced significant improvement in cholesterol and blood pressure levels, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

18 Nov 2020

People with heart disease can receive high-dose or standard-dose flu vaccines for protection

People with heart disease can receive either the high-dose or standard-dose flu vaccines for protection from heart or lung-related deaths or hospitalizations, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

18 Nov 2020

Study highlights the disproportionate burden of COVID-19 among Black, Hispanic patients

Research presented today by UT Southwestern cardiologists at the annual American Heart Association (AHA) Scientific Sessions 2020 showed that Black and Hispanic people were more likely to be hospitalized with COVID-19 than white patients, and that nonwhite men with cardiovascular disease or risk factors were more likely to die.

18 Nov 2020

LOX plays a number of key roles in promoting skin and organ fibrosis in scleroderma

A team of researchers at the Medical University of South Carolina (MUSC) has found that the molecule lysyl oxidase (LOX) plays a number of important roles in promoting skin and organ fibrosis in scleroderma, a connective tissue disorder.

17 Nov 2020

New AHA COVID-19 CVD Registry details the disparities in care

A new American Heart Association collaborative model for COVID-19 research, using data from the new AHA COVID-19 Cardiovascular Disease Registry, found Hispanic and Black adults with COVID-19 were far more likely to be hospitalized than their white counterparts, as were people with obesity and COVID-19, according to three late-breaking research studies presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Study finds more than half of in-hospital COVID-19 deaths among Black, Hispanic patients

More than half of all in-hospital deaths due to COVID-19 during the first six months of 2020 were among Black and Hispanic patients, according to a new study led by researchers at the Stanford University School of Medicine and Duke University.

17 Nov 2020

Overweight and obesity in younger people associated with higher risk of severe COVID-19

Being younger doesn't protect against the dangers of COVID-19 if you are overweight, according to a new study from UT Southwestern.

17 Nov 2020

Study investigates possible link between sleep apnea and autoimmune diseases

New research by University of Georgia scientists sheds light on why people with obstructive sleep apnea may have associated autoimmune disorders. The results could lead to better approaches to treatment and possibly new drug therapies.

17 Nov 2020

Investigational drug helped improve heart health in patients with chronic conditions

The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with Type 2 diabetes and chronic kidney disease, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Cynical hostility poses the greatest risk for cardiovascular disease

Cynical hostility is a potential pathway to cardiovascular disease by preventing a healthy response to stress over time, according to a study led by Baylor University.

17 Nov 2020

Short bursts of intense exercise could help people get fit in time for summer

Short bursts of intense exercise – known as HIIT – could help you get back into shape by summer and stay that way, a UNSW Sydney exercise physiology researcher says.

17 Nov 2020

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Heart attacks, strokes and other cardiovascular incidents can be cut by 20 to 40 per cent through use of a polypill which combines three blood pressure medications and a lipid lowering medication taken alone or with aspirin.

16 Nov 2020

Cardiovascular risk factor control is vital for adults with Type 2 diabetes

Even when risk factors associated with cardiovascular disease are optimally controlled, adults with Type 2 diabetes still have a greater risk of developing cardiovascular disease compared to the general population, according to new research published today in the American Heart Association's flagship journal Circulation.

16 Nov 2020

Metabolic biomarkers could predict COVID-19 severity

A new study suggests that metabolic biomarkers could possibly predict the severity of COVID-19 in patients.

16 Nov 2020

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

New drug reduces LDL cholesterol in patients with severe hypercholesterolemia

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol--the so-called "bad" cholesterol--by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from the Icahn School of Medicine of Mount Sinai and other global academic sites has found.

16 Nov 2020

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study: Pod e-cigarettes are less damaging to health than traditional cigarettes

New data highlights the gaps in care for children with familial hypercholesterolemia

Association between periodontal disease and atherosclerosis in patients with rheumatoid arthritis

Algorithm-driven program improves cholesterol, blood pressure levels

People with heart disease can receive high-dose or standard-dose flu vaccines for protection

Study highlights the disproportionate burden of COVID-19 among Black, Hispanic patients

LOX plays a number of key roles in promoting skin and organ fibrosis in scleroderma

New AHA COVID-19 CVD Registry details the disparities in care

Study finds more than half of in-hospital COVID-19 deaths among Black, Hispanic patients

Overweight and obesity in younger people associated with higher risk of severe COVID-19

Study investigates possible link between sleep apnea and autoimmune diseases

Investigational drug helped improve heart health in patients with chronic conditions

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

Cynical hostility poses the greatest risk for cardiovascular disease

Short bursts of intense exercise could help people get fit in time for summer

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Cardiovascular risk factor control is vital for adults with Type 2 diabetes

Metabolic biomarkers could predict COVID-19 severity

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

New drug reduces LDL cholesterol in patients with severe hypercholesterolemia

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in